Skip to main content
Luke Blagdon Snell

Dr Luke Blagdon Snell

Clinical Research Fellow

Contact details

Biography

Dr Luke Blagdon Snell is a physician specialising in infectious diseases and microbiology, and an MRC Clinical Research Fellow investigating the evolution of viral pathogens. His research interests include the evolution of SARS-CoV-2, the virus that causes COVID-19, during persistent infection in individuals with weakened immune systems.

Related work includes characteristing the properties of SARS-CoV-2 variants, and the interface between the human host and viral pathogen. Collectively within the department, work focuses on the translation of rapid genomics into clinical practice for pathogen identification, prediction of antimicrobial resistance, and outbreak analysis.

    News

    New species of bacteria discovered in unusual human infection

    Researchers at King’s and Guy’s and St Thomas’ NHS Trust have discovered a new species of bacteria, named Variovorax Durovernensis, as a source of a patient’s...

    New bacterial species Jan 2024 v2 780x450

    UK patient had COVID for 505 days

    Researchers from King’s and Guy’s and St Thomas’ NHS Foundation Trust have described the longest known COVID-19 infection.

    covid-patient

    Patient infected with COVID-19 finally cured after 411 days

    A patient infected with an early variant of COVID-19 has been cured after 411 days by using neutralising monoclonal antibodies.

    long-covid

      News

      New species of bacteria discovered in unusual human infection

      Researchers at King’s and Guy’s and St Thomas’ NHS Trust have discovered a new species of bacteria, named Variovorax Durovernensis, as a source of a patient’s...

      New bacterial species Jan 2024 v2 780x450

      UK patient had COVID for 505 days

      Researchers from King’s and Guy’s and St Thomas’ NHS Foundation Trust have described the longest known COVID-19 infection.

      covid-patient

      Patient infected with COVID-19 finally cured after 411 days

      A patient infected with an early variant of COVID-19 has been cured after 411 days by using neutralising monoclonal antibodies.

      long-covid